Expression of A and H blood-group and of CD44 antigens during chemical rat colonic carcinogenesis

Glycoconjugate Journal

Volumn 14, Issue 7, 1997, Pages 801-808

  Hallouin, Florence ^a   Goupille, Caroline ^a   Le Cabellec, Marite ^a   Bara, Jacques ^b   Le Pendu, Jacques ^a  

^a INSTITUT DE BIOLOGIE   (France)

^b CENTRE DE RECHERCHE SAINT ANTOINE   (France)

Author keywords

Adenocarcinoma; Blood group antigens; CD44; Colon; Dimethylhydrazine

Indexed keywords

BLOOD GROUP A ANTIGEN; BLOOD GROUP ANTIGEN; BLOOD GROUP H ANTIGEN; HERMES ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CARCINOGENESIS; COLON ADENOCARCINOMA; COLON BIOPSY; COLON MUCOSA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0030783669     PISSN: 02820080     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018581719944     Document Type: Article

References (45)

1. Oriol R, Mollicone R, Coullin Ph, Dalix AM, Candelier JJ (1992) APMIS Suppl. 27: 28-38.
2. Cooper H, Cox J, Patchefsky AS (1980) Am J Clin Pathol 73: 345-50.
3. Yonesawa S, Nakamura T, Tanaka S, Sato E (1982) J Natl Cancer Inst 69: 777-81.
4. Yuan M, Itzkowitz S, Palekar A, Shamsuddin AM, Phelps PC, Trump BF, Kim YS (1985) Cancer Res 45: 4499-511.
5. Schoentag R, Primus FJ, Kuhns W (1987) Cancer Res 47: 1695-700.
6. Ruggiero F, Cooper HS, Steplewski Z (1988) Lab Invest 59: 96-103.
7. Dabelsteen E, Graem N, Clausen H, Hakomori SI (1988) Cancer Res 48: 181-87.
8. Orntoft TF, Greenwell P, Clausen H, Watkins WM (1991) Gut 32: 287-93.
9. Naitoh H, Nakajima T, Nagamachi Y, Yazawa S (1994) Glycosylation and Disease 1: 31-36.
10. Miyake M, Taki T, Hitomi S, Hakomori SI (1992) N Engl J Med 327: 14-18.
11. Zennadi R, Garrigue L, Ringeard S, Ménoret A, Blanchardie P, Le Pendu J (1992) Int J Cancer 52: 934-40.
12. Labarrière N, Piau JP, Otry C, Denis M, Lustenberger P, Meflah K, Le Pendu J (1994) Cancer Res 54: 6275-81.
13. Ménoret A, Otry C, Labarrière N, Breimer ME, Piller F, Meflah K, Le Pendu J (1995) J Cell Sci 108: 1691-701.
14. Herrlich P, Zöller M, Pals ST, Ponta H (1993) Immunol Today 14: 395-99.
15. Faassen A, Schrager JA, Klein DJ, Oegema TR, Couchman JR, McCarthy JB (1992) J Cell Biol 116: 521-31.
16. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B (1990) Cell 61: 1303-13.
17. Jalkanen S, Jalkanen M (1992) J Cell Biol 116: 817-25.
18. Günthert U, Hofmann M, Rudy W, Reber S, Zöller M, Haußmann I, Matzku S, Wenzel A, Ponta H, Herrlich PA (1991) Cell 65: 13-24.
19. Mulder JWR, Kruyt PM, Sewnath M, Oosting J, Seldenrij CA, Weidema WF, Offerhaus GJA, Pals ST (1994) The Lancet 344: 1470-72.
20. Kaufmann M, Heider KH, Sinn HP, von Minkwitz G, Ponta H, Herrlich P (1995) The Lancet 345: 615-19.
21. Sunter JP, Appleton DR, Wright NA, Watson AJ (1978) Virchows Arch B Cell Path 29: 211-23.
22. Farber E, Cameron R (1980) Adv Cancer Res 35: 125-26.
23. Martin MS, Martin F, Michaels R, Bastien H, Justrabo E, Bordes M, Viry B (1973) Digestion 8: 22-34.
24. Caignard A, Martin MS, Michel MF, Martin F (1985) Int J Cancer 36: 273-79.
25. Pereira MEA, Kisalius EC, Gruezo F, Kabat EA (1978) Arch Biochem Biophys 185: 108-15.
26. Good AH, Yau O, Lamontagne LR, Oriol R (1992) Vox Sang 62: 180-89.
27. Nakajima T, Yazawa S, Miyazaki S, Furukawa (1993) J Immunol Methods 159: 261-67.
28. Clausen H, Levery SB, Kannagi R, Hakomori SI (1986) J Biol Chem 261: 1380-87.
29. Bara J, Gautier R, Le Pendu J, Oriol R (1988) Biochem J 254: 185-93.
30. Decaens C, Gautier R, Bara J, Daher N, Le Pendu J, Burtin P (1988) Cancer Res 48: 1571-77.
31. Filipe MI (1975) Br J Cancer 32: 60-77.
32. Wirth K, Arch R, Somasundaran C, Hofmann M, Weber B, Herrlich P, Matzku S, Zöller M (1993) Eur J Cancer 29A: 1172-77.
33. Norrsell H, Bengtsson J, Jovall PA, Hansson GC (1992) Eur J Biochem 203: 285-93.
34. Hansson GC, Karlsson KA, Thurin J (1984) Biochim Biophys Acta 792: 281-92.
35. Decaens C, Nardelli J, Gautier R, Bara J, Burtin P (1986) Tumor Biol 7: 371-87.
36. Blottière HM, Ménoret A, Grégoire M, Douillard JY, Meflah K, Le Pendu J (1991) Biol Cell 72: 239-47.
37. Freeman HJ, Lotan R, Kim YS (1980) Lab Invest 42: 405-12.
38. Caldero J, Campo E, Calomarde X, Torra M (1988) Histochem 90: 261-70.
39. Caldero J, Campo E, Vinas J, Cardesa A (1989) Lab Invest 61: 670-76.
40. Bara J, Mollicone R, Herrero-Zabaleta E, Gautier R, Daher N, Oriol R (1988) Int J Cancer 41: 683-89.
41. Wielenga VJM, Heider KH, Offerhaus JA, Adolf GR, van den Berg FM, Ponta H, Herrlich P, Pals S (1993) Cancer Res 53: 4754-56.
42. Heider KH, Hofmann M, Hors E, van den Berg F, Ponta H, Herrlich P, Pals ST (1993) J Cell Biol 120: 227-33.
43. Mulder JWR, Wielenga VJM, Polak MM, van den Berg FM, Adolf GR, Herrlich P, Pals ST, Offerhaus GJA (1995) Gut 36: 76-80.
44. Orzechowski HD, Beckenbach C, Herbst H, Stölzel U, Riecken EO, Stallmach A (1995) Eur J Cancer 31A: 2073-79.
45. Goupille C, Hallouin F, Meflah K, Le Pendu J (1997) Glycobiol 7: 221-29.